SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-011079
Filing Date
2024-08-06
Accepted
2024-08-06 16:05:49
Documents
79
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20240630x10q.htm   iXBRL 10-Q 2327800
2 EX-10.1 rigl-20240630xex10d1.htm EX-10.1 177297
3 EX-10.2 rigl-20240630xex10d2.htm EX-10.2 144569
4 EX-31.1 rigl-20240630xex31d1.htm EX-31.1 15896
5 EX-31.2 rigl-20240630xex31d2.htm EX-31.2 16782
6 EX-32.1 rigl-20240630xex32d1.htm EX-32.1 9073
7 GRAPHIC rigl-20240630x10q006.jpg GRAPHIC 88487
  Complete submission text file 0001558370-24-011079.txt   9393670

Data Files

Seq Description Document Type Size
8 EX-101.SCH rigl-20240630.xsd EX-101.SCH 56771
9 EX-101.CAL rigl-20240630_cal.xml EX-101.CAL 61207
10 EX-101.DEF rigl-20240630_def.xml EX-101.DEF 222027
11 EX-101.LAB rigl-20240630_lab.xml EX-101.LAB 478147
12 EX-101.PRE rigl-20240630_pre.xml EX-101.PRE 358129
82 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20240630x10q_htm.xml XML 1548136
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 241179126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)